Mexiletine labels and packages: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Mexiletine}} {{CMG}}; {{AE}} {{SS}}; {{AZ}} ==Labels And Packages== {| |thumb|600px |} {| |File:Mexilitine 200mg.PNG|thumb|600p...") |
Ahmed Zaghw (talk | contribs) |
||
| Line 10: | Line 10: | ||
{| | {| | ||
|[[File:Mexilitine 200mg.PNG|thumb|600px]] | |[[File:Mexilitine 200mg.PNG|thumb|600px]] | ||
|} | |||
} | |||
{| | {| | ||
|[[File:Mexilitine 250mg.JPG|thumb|600px]] | |[[File:Mexilitine 250mg.JPG|thumb|600px]] | ||
|} | |||
.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=693da40b-26d4-40d6-87d1-158e256f40ab | publisher = | date = | accessdate = 3 March 2014 }}</ref> | |||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 15:47, 10 March 2014
| Mexiletine |
|---|
| MEXILETINE HYDROCHLORIDE® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Mexiletine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]; Ahmed Zaghw, M.D. [3]
Labels And Packages
 |
 |
 |
.[1]
References
- ↑ "MEXILETINE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC]". Retrieved 3 March 2014.